Delivery confirmation for e-mail
    1.
    发明申请
    Delivery confirmation for e-mail 有权
    电子邮件的送货确认

    公开(公告)号:US20070136430A1

    公开(公告)日:2007-06-14

    申请号:US11301862

    申请日:2005-12-13

    IPC分类号: G06F15/16

    CPC分类号: H04L51/30 H04L51/34

    摘要: A delivery confirmation is provided to the sender of an e-mail message. When the e-mail message is composed, a link, such as a hyperlink, is inserted into the e-mail message, such as in the body or header. The link can include information such as a message identifier and identifiers of the sender and the recipient, which are provided as a query string of the link, while a host field of the link includes the address of an e-mail/web server. When the recipient receives the e-mail message and opens it, the link is displayed along with text that instructs the user to use the link to confirm delivery. The confirmation can include displaying indicia for the e-mail message in a folder view on an interface of the sender, or sending a confirmation e-mail message to the sender, for instance. Voting by e-mail can also be provided.

    摘要翻译: 向电子邮件的发送者提供发送确认。 当电子邮件组合时,诸如超链接的链接被插入电子邮件消息中,例如在主体或头部中。 链接可以包括作为链接的查询字符串提供的信息,例如消息标识符和发送者和接收者的标识符,而链接的主机字段包括电子邮件/ web服务器的地址。 当收件人收到电子邮件并打开邮件时,会显示链接以及指示用户使用链接确认传送的文字。 该确认可以包括在发送者的接口上的文件夹视图中显示电子邮件的标记,或者例如向发送者发送确认电子邮件消息。 也可以通过电子邮件投票。

    PENTOXIFILIN-BASED DERMATOLOGICAL PHARMACEUTICAL COMPOSITION, FOR TOPICAL APPLICATION, IN CREAM, GEL, SOLUTION, EMULSION, LIPOSOME AND MICROCAPSULE FORM
    2.
    发明申请
    PENTOXIFILIN-BASED DERMATOLOGICAL PHARMACEUTICAL COMPOSITION, FOR TOPICAL APPLICATION, IN CREAM, GEL, SOLUTION, EMULSION, LIPOSOME AND MICROCAPSULE FORM 审中-公开
    基于PENTOXIFILIN的皮肤药理学组合物,用于局部应用,乳膏,凝胶,溶液,乳液,脂质体和微阵列

    公开(公告)号:US20110159077A1

    公开(公告)日:2011-06-30

    申请号:US12737961

    申请日:2009-08-25

    摘要: A pharmaceutical dermatological composition based on Pentoxifylline, to be applied on the skin in the form of a cream, gel, unguent, solution, in an emulsion, in liposomes and in microcapsules, being selective for the vascular disorders of rosacea and disorders with photosensitivity, reducing the blood vessels and the reactions of reddening of the skin, CHARACTERIZED in that said composition consists of: from 1% to 99% of Pentoxifylline, from 0.1% to 80% of base cream and from 0.1% to 75% of liposomes.

    摘要翻译: 一种基于己酮可可碱的药物皮肤病学组合物,其以霜剂,凝胶,无溶剂,乳剂,脂质体和微胶囊形式施用在皮肤上,对于红斑痤疮和具有光敏性的病症的血管疾病是有选择性的, 减少血管和皮肤红化的反应,其特征在于所述组合物由1%至99%的己酮可可碱,0.1%至80%的基础霜和0.1%至75%的脂质体组成。